Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Bram L. T. Ramaekers*, Robert F. Wolff, Xavier Pouwels, Marije Oosterhoff, Anoukh Van Giessen, Gill Worthy, Caro Noake, Nigel Armstrong, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)917-927
Number of pages11
JournalPharmacoeconomics
Volume36
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Cite this